Product Information
QUINIDINE GLUC ER 324 MG TAB is a generic product labeled by Eywa Pharma Inc, priced at $4.9220 per EA under NDC 71930001612. Its NADAC has been published 107 times since Sep 18, 2024.
FDA first approved this application on Sep 17, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
324 mg/1
Manufacturer
Eywa Pharma IncNDC
71930001612
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
QUINIDINE GLUCONATEApproval Type
Generic (ANDA)
FDA Application
ANDA212589FDA Approved
9/17/2021
TE Code
AB
On Market Since
3/20/2022
Pharmacological Classes
Price Statistics
The NADAC for QUINIDINE GLUC ER 324 MG TAB has been published 107 times since Sep 18, 2024, and over the history we have for it it has declined 23.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.9220 per EA |
|---|---|
| All-time high | $6.4573 (Oct 16, 2024) |
| All-time low | $4.8814 (Sep 17, 2025) |
| 52-week high | $6.1633 |
| 52-week low | $4.8814 |
| Median price | $5.7318 |
| Average price | $5.6171 |
| Largest weekly change | -24.0% (Sep 17, 2025) |
| Weeks tracked | 107 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Quinidine gluonate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eywa Pharma Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Quinidine gluonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiarrhythmic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QUINIDINE GLUC ER 324 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for QUINIDINE GLUC ER 324 MG TAB, manufactured by Eywa Pharma Inc, is $4.9220 per EA (NDC 71930001612), effective Sep 30, 2026.
How has the price of QUINIDINE GLUC ER 324 MG TAB changed over time?
Over the history we have for it, the NADAC for QUINIDINE GLUC ER 324 MG TAB has declined 23.8%. It has been tracked across 107 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for QUINIDINE GLUC ER 324 MG TAB?
Since Sep 18, 2024, the NADAC for QUINIDINE GLUC ER 324 MG TAB has ranged from a low of $4.8814 (Sep 17, 2025) to a high of $6.4573 (Oct 16, 2024), with a median of $5.7318 per EA.
Are there cheaper alternatives to QUINIDINE GLUC ER 324 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of QUINIDINE GLUC ER 324 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QUINIDINE GLUC ER 324 MG TAB?
QUINIDINE GLUC ER 324 MG TAB (NDC 71930001612) is labeled by Eywa Pharma Inc, and CMS classifies it as a generic product.